Improving QoL through the use of STAT-ON™. by Daniel Rodriguez-Martin (22411006)

“…While medication costs may increase, overall direct healthcare expenses decrease, leading to net savings. As an example, the study estimates potential cost reductions of up to €137.8 million in Germany and €19 million in Sweden when STAT-ON™ is used to detect advanced PD symptoms. …”

Plots and stats. by Changseok Lee (6832547)

Tissue, days post-infection (dpi) and the top 10 most significant genes with increased and decreased expression with valid gene symbols for the response contrasts. by Gillian P. McHugo (8965919)

The raw data used to support the findings of this study. by Shuaini Yang (20670608)

STAT3, EBNA1, and ZC3H18 regulate MYC with ZC3H18 also regulating STAT3 and EBNA1. by Huanzhou Xu (8129922)

pI7L inhibits the IFN-<i>γ</i>-triggered JAK-STAT signaling pathway by targeting STAT1. by Meilin Li (1832905)

STAT3 inhibitor LLL12B impairs cell growth and induces apoptosis. by Huanzhou Xu (8129922)

STAT3 and MYC enrich at <i>STAT3</i> and <i>ZC3H18</i> promoters while EBNA1 predominantly enriches at the <i>BKRF1</i> (EBNA1) promoter. by Huanzhou Xu (8129922)

STAT3, MYC, and EBNA1 regulate ZC3H18 and each other. by Huanzhou Xu (8129922)

Model depicting the relationships between STAT3, MYC, EBNA1, and ZC3H18. by Huanzhou Xu (8129922)

GI-1d-a: Comparison of estimates of people for dataset A (left bar) and B (right bar) per region. The largest discrepancies occur in areas of NE, SE and SW Germany and adjacent reg... by Isabell Schmidt (6331013)

Newly developed inhibitors of STAT3, MYC, and EBNA1 suppress the abundance of ZC3H18. by Huanzhou Xu (8129922)

Scenario 1. Moderate patient with STAT-ON™. by Daniel Rodriguez-Martin (22411006)

“…While medication costs may increase, overall direct healthcare expenses decrease, leading to net savings. As an example, the study estimates potential cost reductions of up to €137.8 million in Germany and €19 million in Sweden when STAT-ON™ is used to detect advanced PD symptoms. …”

Scenario 2. Advanced patient with STAT-ON™. by Daniel Rodriguez-Martin (22411006)

“…While medication costs may increase, overall direct healthcare expenses decrease, leading to net savings. As an example, the study estimates potential cost reductions of up to €137.8 million in Germany and €19 million in Sweden when STAT-ON™ is used to detect advanced PD symptoms. …”

Innovation, nightlights and a continuous measure of city size. by Saul Estrin (8629173)

pI7L inhibits STAT1 phosphorylation and blocks its nuclear translocation. by Meilin Li (1832905)

pI7L suppresses the IFN-γ-triggered JAK-STAT signaling pathway. by Meilin Li (1832905)

Selection frequencies plotted in decreasing order. by Hannah P. Rowe (7830599)

pI7L inhibits the phosphorylation of STAT1 depending on its tyrosine at position 98. by Meilin Li (1832905)

Data Sheet 1_The role and impact of the IL-6 mediated JAK2-STAT1/3 signaling pathway in the pathogenesis of gout.zip by Zeng Zhang (299463)

“…IL-6 expression was manipulated using IL-6 agonists and IL-6 knockout (KO) mouse technology to investigate the role and impact of the IL-6-mediated JAK2-STAT1/3 signaling pathway in gout models. …”